A strong first-quarter sent the pharmaceutical company’s shares northward, but this positive momentum is starting to fade after a key regulatory setback. …read more
Source:: Yahoo Finance
A strong first-quarter sent the pharmaceutical company’s shares northward, but this positive momentum is starting to fade after a key regulatory setback. …read more
Source:: Yahoo Finance
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.